Australian Respiratory and Sleep Medicine Institute Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2015
NCT02335164
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ARASMI | Australian Respiratory and Sleep Medicine Institute